SurModics (SRDX) – FDA
-
SurModics (SRDX) Announces Successful Early Clinical Use of Pounce Thrombectomy System
-
SurModics (SRDX) Announces TRANSCEND Trial 36-Month Data
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to SRDX Stock Lookup